| Pharmaceutical active ingredients: |
| Cilastatin SodiumImipenem |
| Available forms, composition and doses of Primaxin IV: |
| Injectable; Injection; Cilastatin Sodium 250 mg; Imipenem 250 mgInjectable; Injection; Cilastatin Sodium 500 mg; Imipenem 500 mg |
| Primaxin IV medical category: |
| Human:Beta-LactamsCarbapenems |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J01DH51 - Imipenem and enzyme Inhibitor |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Merck |
| Related documents and information about Primaxin IV: |
| Primaxin prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Penam | Cilastatin Sodium; Imipenem | Jeil Pharmaceutical; International Apex Pharmaceuticals |
| Penexil | Cilastatin Sodium; Imipenem | Quimica Haller |
| Plastin | Cilastatin Sodium; Imipenem | Taiwan Biotech; Phil Pharmawealth |
| Primaxin | Cilastatin Sodium; Imipenem | Merck; Vianex |
| Primaxin IM | Cilastatin Sodium; Imipenem | Merck |
| Ran-Imipenem-Cilastatin | Cilastatin Sodium; Imipenem | Ranbaxy |
| Tenacid | Cilastatin Sodium; Imipenem | Sigma-Tau Pharmaceuticals |
| Timipen | Cilastatin Sodium; Imipenem | Interbat |
| Tracix | Cilastatin Sodium; Imipenem | Merck |
| Zienam | Cilastatin Sodium; Imipenem | Merck |